Shuzhi Lin

2.4k total citations
12 papers, 23 citations indexed

About

Shuzhi Lin is a scholar working on Epidemiology, Oncology and Toxicology. According to data from OpenAlex, Shuzhi Lin has authored 12 papers receiving a total of 23 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Oncology and 3 papers in Toxicology. Recurrent topics in Shuzhi Lin's work include Chronic Disease Management Strategies (4 papers), Biosimilars and Bioanalytical Methods (3 papers) and Diabetes Management and Education (3 papers). Shuzhi Lin is often cited by papers focused on Chronic Disease Management Strategies (4 papers), Biosimilars and Bioanalytical Methods (3 papers) and Diabetes Management and Education (3 papers). Shuzhi Lin collaborates with scholars based in China. Shuzhi Lin's co-authors include Wang Ning-sheng, Haisheng You, Yue Chen, Wei Liu, Wei Liu, Xinde Zheng, Lin Yin, Lin Yin, Qian Liu and Lin Yin and has published in prestigious journals such as Frontiers in Immunology, International Journal of Environmental Research and Public Health and Frontiers in Pharmacology.

In The Last Decade

Shuzhi Lin

10 papers receiving 23 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuzhi Lin China 3 5 4 3 3 3 12 23
Laura Ruppert United States 4 4 0.8× 6 1.5× 1 0.3× 3 1.0× 4 36
Sabah Al-Marwani Jordan 2 3 0.6× 4 1.0× 2 0.7× 2 31
Kim Heng Tay Malaysia 2 5 1.0× 5 1.3× 2 0.7× 4 1.3× 2 15
Sajjad Pourasghary Iran 3 6 1.2× 3 0.8× 1 0.3× 3 1.0× 7 18
Moonis Mirza India 4 3 0.6× 3 0.8× 5 1.7× 7 21
Prashant Mathur India 4 8 1.6× 4 1.0× 3 1.0× 9 39
Aurélie Veislinger France 3 5 1.0× 2 0.5× 3 1.0× 5 18
Robert W Follett United States 4 4 0.8× 4 1.3× 5 1.7× 7 2.3× 5 21
Ian Homer Philippines 2 8 1.6× 4 1.0× 2 0.7× 4 17
Elena Bustamante‐Munguira Spain 3 3 0.6× 4 1.0× 2 0.7× 5 24

Countries citing papers authored by Shuzhi Lin

Since Specialization
Citations

This map shows the geographic impact of Shuzhi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuzhi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuzhi Lin more than expected).

Fields of papers citing papers by Shuzhi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuzhi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuzhi Lin. The network helps show where Shuzhi Lin may publish in the future.

Co-authorship network of co-authors of Shuzhi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shuzhi Lin. A scholar is included among the top collaborators of Shuzhi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuzhi Lin. Shuzhi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zheng, Xinde, Shuzhi Lin, Zefeng Cai, & Jilin Li. (2025). Association between cardiovascular-kidney-metabolic syndrome and risk of low cognitive function in older adults: Data from the NHANES 2011–2014. Journal of Alzheimer s Disease. 106(4). 1523–1532. 1 indexed citations
2.
Lin, Shuzhi, et al.. (2025). Pharmacovigilance-related events, disease burden and overall efficiency of care in european countries, 1990-2021. Frontiers in Pharmacology. 16. 1592957–1592957.
3.
4.
Liu, Wei, et al.. (2024). The short- and long-term effects of community-family-doctor-based type 2 diabetes self-management interventions. Public Health. 230. 96–104. 1 indexed citations
5.
6.
7.
Lin, Shuzhi, et al.. (2024). Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study. International Journal of Clinical Pharmacy. 46(5). 1076–1090. 2 indexed citations
8.
Lin, Shuzhi, et al.. (2023). Safety analysis of therapeutic drugs for breast cancer patients and construction of a predictive model for serious adverse drug reactions. European Journal of Clinical Pharmacology. 80(2). 249–259. 1 indexed citations
9.
Ning-sheng, Wang, et al.. (2023). Safety analysis of antineoplastic drugs for lung cancer: a retrospective analysis based on Shaanxi Province in Western China. Expert Opinion on Drug Safety. 23(1). 99–105. 1 indexed citations
10.
11.
12.
Lin, Shuzhi, et al.. (2022). Use of Failure Mode and Effects Analysis (FMEA) for Risk Analysis of Drug Use in Patients with Lung Cancer. International Journal of Environmental Research and Public Health. 19(23). 15428–15428. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Ruppert Breakdown of academic impact, for papers by Sabah Al-Marwani Breakdown of academic impact, for papers by Kim Heng Tay Breakdown of academic impact, for papers by Sajjad Pourasghary Breakdown of academic impact, for papers by Moonis Mirza Breakdown of academic impact, for papers by Prashant Mathur Breakdown of academic impact, for papers by Aurélie Veislinger Breakdown of academic impact, for papers by Robert W Follett Breakdown of academic impact, for papers by Ian Homer Breakdown of academic impact, for papers by Elena Bustamante‐Munguira
Rankless by CCL
2026